Best Life Sciences Tech Companies in France
The 148 best Life Sciences Tech companies in France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Owkin.
France's Life Sciences Tech sector doesn't have a funding problem. Our directory tracks 148 companies with $903M in total disclosed capital, and Owkin alone accounts for $321M of that, which tells you something real about where conviction concentrates. Aqemia sits at $63M, Bioptimus at $35M, SeqOne at $26M. That's a small cluster of outsized earners pulling the median up. And France has exactly one unicorn in the mix, so the runway ahead is longer than the hype suggests.
What's actually moving the needle? Across life sciences tech apps, median install growth is running at roughly 43% year over year, a momentum figure I'd take seriously as a leading indicator of where earned revenue follows. Regulatory compliance and intellectual property protection are named demand drivers for a reason: the companies here aren't just building tools, they're building infrastructure that regulators eventually require everyone to use. Bpifrance, EIT Health, and Cathay Innovation keep appearing on cap tables, which means institutional patience is baked in. If you're trying to map where durable revenue is forming in French Life Sciences Tech, the funding distribution across these 148 companies is your clearest signal.
- EVERSANA
- LifeSciencesIntelligence
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in France
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Owkin 🦄 AI generative biology company to create the new standard of biology reasoning 89AI top 18%Innovation top 21%Patents top 21%Funding top 23% All 12 signals ▾AItop 18% Innovationtop 21% Patentstop 21% Fundingtop 23% Growthtop 23% Moattop 25% Globaltop 34% Fin. healthtop 37% Talenttop 38% Markettop 40% Techtop 46% Newsbottom 27% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Innovation: 49 patents (top 29% of patent-holders) · 39 filings since 2022 vs 10 in 2017-21 rank vs industry peers · Fliar Intelligence Index 89/100 | $321M | 3 mo ago | 47 | Gilles Wainrib Co-Founder | WebflowApple iCloud MailGoogle Workspace+21 | 25 patents AI-powered medical imaging analysis for cancer prognosis and federated learning networks | 1 launch |
| 2 | Enterome Developer of immunomodulatory drugs targeting cancer and immune diseases | $130M | 71 mo ago | 70 | — | — | 188 patents Microbiome-derived antigenic peptides for cancer immunotherapy and B‑cell malignancy treatment | — |
| 3 | Inova Cloud-based biopharma CRM and CRO collaborating system for the life science industry | $71M | 59 mo ago | 137 | David Carteret Co-Founder | — | 5 patents Heat‑resistant culinary apparel with elastic closures for improved chef comfort | — |
| 4 | Aqemia Provider of an AI and quantum physics to discover therapeutic molecules 60Funding top 28%AI top 30%Moat top 38%Tech top 39% All 11 signals ▾Fundingtop 28% AItop 30% Moattop 38% Techtop 39% Innovationtop 44% Growthtop 48% Patentstop 49% Talentbottom 49% Marketbottom 44% Globalbottom 36% Newsbottom 18% Funding: Raised $62.7M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) AI: Classified as an AI company · Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 60/100 | $63M | 14 mo ago | 60 | Maximilien Levesque Founder & CEO | WebflowApple iCloud MailGoogle Workspace+15 | 4 patents Small-molecule inhibitors of METTL3 RNA methyltransferase and MAP4K1 kinase for therapeutic use | 1 job opening |
| 5 | Depixus Provider of solutions for single-molecule genetic and epigenetic sequencing | $47M | 54 mo ago | 68 | Gordon Hamilton Co-Founder & CEO | — | 53 patents Patents concentrated in chemistry & materials | — |
| 6 | Kayentis Provider of electronic clinical outcome assessment solutions for clinical trials | $36M | 38 mo ago | 12 | Philippe Berna Founder | WordPressMySQLPHP+25 | — | 2 job openings · 2 launchs |
| 7 | Inato AI-based patient recruitment platform | $36M | 38 mo ago | 49 | Philippe Ravaud Co-Founder | — | — | — |
| 8 | Bioptimus Developer of AI foundation model to transform biological research 64AI top 20%Talent top 23%Funding top 33%Growth top 35% All 9 signals ▾AItop 20% Talenttop 23% Fundingtop 33% Growthtop 35% Moattop 42% Techbottom 49% Globalbottom 38% Marketbottom 36% Newsbottom 18% AI: Classified as an AI company Talent: 6 named leaders on record · 6 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 64/100 | $35M | 17 mo ago | — | Jean-Philippe Vert Co-Founder | WebflowGSAPMicrosoft Advertising+16 | — | 2 launchs · 1 partnership |
| 9 | Adents Provider of serialization software solutions mainly for the pharmaceutical industry | $27M | 119 mo ago | 31 | Christophe Devins Co Founder | — | — | — |
| 10 | SeqOne Provider of bioinformatics tools for the analysis of genome sequencing data 55Growth top 32%Moat top 37%Funding top 38%Patents top 44% All 10 signals ▾Growthtop 32% Moattop 37% Fundingtop 38% Patentstop 44% Innovationtop 47% Techtop 48% Markettop 50% Talentbottom 49% Globalbottom 36% Newsbottom 20% Growth: Web rank 10,000,000 → 5,000,000 YoY · 1 acquisition/expansion move in 24 mo Moat: Editorial + unicorn rating 6/10 · IP moat: 18 patents rank vs industry peers · Fliar Intelligence Index 55/100 | $26M | 12 mo ago | 70 | Nicolas Philippe CEO | WebflowApple iCloud MailGoogle Workspace+19 | 18 patents Bioinformatics platforms for genomic HRD detection, structural variant identification, and phenotyping support | 1 partnership |
| 11 | DeepLife Provider of AI-based drug discovery and omics analysis tool for researchers 37AI top 22%Funding top 40%Moat top 45%Patents top 48% All 8 signals ▾AItop 22% Fundingtop 40% Moattop 45% Patentstop 48% Innovationtop 49% Talentbottom 49% Globalbottom 39% Marketbottom 24% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $16.4M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 37/100 | $16M | 18 mo ago | 10 | Jonathan Baptista Co-Founder & CEO | — | 4 patents Patents concentrated in computing, sensing & instrumentation | 1 award |
| 12 | Iktos Artificial Intelligence for new drug design | $16M | 39 mo ago | 55 | Nicolas Do Huu Co-Founder & CTO | PrismicNode.jsThree.js+14 | — | — |
| 13 | Kadrige Solutions and services for promotion, information, training and remote management to the pharmaceutical… | $15M | 165 mo ago | 50 | Olivier Cadou Founder & CEO | — | 11 patents Networked remote screen control and automatic communication session recording. | — |
| 14 | WhiteLab Genomics Provider of drug discovery and development platform | $10M | 45 mo ago | 29 | David Del Bourgo CEO co-founder | SkolengoSentryApple iCloud Mail+20 | 4 patents ML-driven phenotype prediction and cell‑surface protein identification for functional genomics | — |
| 15 | Kyron.bio Developer of bioproduction platform for drug discovery and development 27Growth top 35%Funding top 45%Talent bottom 49%Tech bottom 45% All 6 signals ▾Growthtop 35% Fundingtop 45% Talentbottom 49% Techbottom 45% Globalbottom 36% Marketbottom 17% Growth: Fresh capital in last 24 mo Funding: Raised $7.7M across 4 rounds · 4 rounds over 3 yrs (1.3/yr) rank vs industry peers · Fliar Intelligence Index 27/100 | $8M | 12 mo ago | 6 | Emilia McLaughlin Founder | WixSentryBootstrap+10 | — | — |
| 16 | Biolevate AI-powered platform to accelerate scientific innovation and improve knowledge management in the life sciences… 24Funding top 43%AI top 45%Talent bottom 49%Tech bottom 40% All 6 signals ▾Fundingtop 43% AItop 45% Talentbottom 49% Techbottom 40% Globalbottom 36% Marketbottom 25% Funding: Raised $6.3M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 24/100 | $6M | 18 mo ago | — | Joel Belafa Co-Founder & CEO | Framer SitesReactPriority Hints+7 | — | — |
| 17 | Intrasense Designs, develops a software suite for the advanced visualization and post-processing of multimodal medical… | $6M | 125 mo ago | 61 | — | WordPressMySQLSalesforce+28 | 23 patents Advanced lung image processing, ROI mapping, and interactive visualization for medical diagnostics | 1 launch · 1 partnership |
| 18 | Median Provider of medical imaging software and services for clinical trials usage | $5M | 62 mo ago | 163 | Fredrik Brag Founder & CEO | WordPress Site EditorWordPressApple iCloud Mail+20 | 2 patents Automated quantitative texture analysis and lesion classification in chest CT imaging. | 1 partnership |
| 19 | Scienta Lab Provider of data-driven models to support drug development and clinical strategies | $4M | 30 mo ago | 7 | Camille Bouget Co-Founder & CEO | WebflowGSAPSwiper+10 | — | — |
| 20 | Datexim Datexim | AI-powered Healthcare Solutions | Digital Pathology | $3M | 68 mo ago | 19 | — | — | — | — |
| 21 | Ariana Pharma Develops clinical data analysis and diagnostic testing solutions. | $2M | 215 mo ago | 22 | — | WordPressMySQLPHP+24 | — | — |
| 22 | GenSensor Developer of robotic devices and analytics software for bioproduction monitoring | $2M | 34 mo ago | 5 | Jean-Marie Charpin Co-Founder & President | — | — | — |
| 23 | Primaa Provider of AI-based software for detection of cancer 40AI top 35%Talent top 38%Funding top 42%Moat top 48% All 7 signals ▾AItop 35% Talenttop 38% Fundingtop 42% Moattop 48% Techbottom 38% Globalbottom 37% Marketbottom 35% AI: Product described with: ai-based, artificial intelligence Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 40/100 | $2M | 7 mo ago | 35 | Stephane Sockeel Chief Scientific Officer and Co-Founder | WordPressMySQLPHP+19 | — | 1 partnership · 2 awards |
| 24 | Klineo Digital clinical data and trial management tool for doctors and researchers | $2M | 25 mo ago | — | Nicolas Drizard CTO & Co-Founder | SentryNode.jsNextAuth.js+20 | — | 1 internship · 4 partnerships |
| 25 | Iconeus Digital animal brain imaging and analysis device for researchers | $2M | 44 mo ago | 30 | — | WordPress Site EditorWordPressMySQL+20 | 25 patents Medical ultrasound systems for real-time brain vascular and physiological monitoring | — |
| 26 | GreenTropism Provider of software components for mainstream and industrial spectroscopy | $1M | 106 mo ago | 13 | Anthony Boulanger Founder & CEO | — | 31 patents Rapid pathogen detection in biological fluids using surface-enhanced Raman spectroscopy | — |
| 27 | Bilhi Genetics Disease prediction algorithms using genetic markers | $1M | 124 mo ago | 11 | Bruno Dessein Co-Founder | — | — | — |
| 28 | Discngine Provider of services and solutions for the life sciences industry | $1M | 97 mo ago | 68 | — | — | — | 1 launch |
| 29 | BIONEXT Software for drug design and research | $1M | 136 mo ago | 7 | — | — | 100 patents Patents concentrated in chemistry & materials | — |
| 30 | Meddenovo Developer of computational biochemistry software for pharmaceutical research and development | $1M | 22 mo ago | — | Ilke Marion Co-Founder | — | — | — |
| 31 | Cybernano Biostatistics services | $861K | 89 mo ago | 7 | Thierry Bastogne Co-founder & Chief Scientific Officer | — | 3 patents Bioprocess control in bioreactors and personalized respiratory monitoring devices | 1 partnership |
| 32 | Notocord Life sciences software publisher | $647K | 77 mo ago | 11 | — | — | — | — |
| 33 | Keen Eye Manufacturer of drug development services for image analysis | $610K | 77 mo ago | 21 | — | — | 13 patents Patents concentrated in computing, sensing & instrumentation | — |
| 34 | ETISENSE Developer of a wearable cardio-respiratory monitoring device | $508K | 71 mo ago | — | Timothe Flenet Co-Founder & CEO | — | 14 patents Wearable inductive plethysmography vests for physiological monitoring of small mammals | 1 partnership |
| 35 | Triacys Triacys offers technology solutions and services for clinical trials. | $485K | 132 mo ago | — | Hertsel Adhoute Founder | — | — | — |
| 36 | Dexstr Digital clinical data management tool for providers | $336K | 128 mo ago | 8 | — | — | — | — |
| 37 | Nova In Silico Developer of AI-driven in silico clinical trial platform for improving decision-making in biology, medicine… | $310K | 129 mo ago | — | François-Henri Boissel Co-founder & CEO | WordPressMySQLPHP+18 | — | 1 launch |
| 38 | Interactive biosoftware Provider of software tools to analyze next-gen sequencing data sets | $90K | 129 mo ago | 10 | — | — | — | — |
| 39 | eNovalys Reaction database for medicinal chemists. | $19K | 138 mo ago | — | Frank Hoonakker Co-Founder & CEO | — | — | — |
| 40 | Inpart Platform connecting scientific decision makers with research, assets, and expertise | — | 59 mo ago | — | Gilles Toulemonde Co-Founder & CEO | SanityApple iCloud MailMicrosoft 365+17 | — | — |
| 41 | MAK-SYSTEM Laboratory information management software for blood, plasma, tissue and cell centers | — | 76 mo ago | 117 | Simon Kiskovski Founder | WordPressSentryMySQL+23 | — | — |
| 42 | Arsenal Chirurgical Online platform for healthcare communications | — | 77 mo ago | — | Pierre Cosson Founder | — | — | — |
| 43 | Cegedim Digital data flow management services | — | 77 mo ago | 6,469 | Laurent Labrune CEO | Apple iCloud MailNode.jsVimeo+13 | 4 patents Remote network-based presentation and control of display screens | — |
Top 12 Life Sciences Tech companies in France
#1
Owkin 🦄Series B · Paris, Ile de France · founded 2016 · 47 employees$321.1Mraised▾
AI generative biology company to create the new standard of biology reasoning. The company is creating the only large-scale reasoning model trained natively on patient-level multimodal data and reinforced through real biological feedback — a closed-loop system that continuously improves itself. It is building the operating system for biology a platform in general-purpose biology intelligence.
- Mar 2026Series B$33M
- Jan 2023Grant (prize money)$216.4K
- Jun 2022Series B$80M
- Nov 2021Series B$180M
#2
Series A · Paris, Ile de France · founded 2019 · 60 employees$62.7Mraised▾
Provider of an AI and quantum physics to discover therapeutic molecules. The software uses AI-Based technology for screening different small molecules, knowing its physical properties helping in upstream processing and drug discovery. The software also helps in determining therapeutic targets responsible for particular diseases.
- Apr 2025Grant (prize money)$7.4M
- Dec 2024Series A$40.1M
- Jan 2024Series A$32.5M
- Oct 2022Series A$29.1M
#3
Series A · Montpellier, Occitanie · founded 2017 · 70 employees$26.1Mraised▾
Provider of bioinformatics tools for the analysis of genome sequencing data. The platform helps researchers to detect & identify the variants responsible for gene mutation. It helps to detect many types of variants such as SNPs, Indels, CNVs, and mid-sized deletions.
- May 2025Series A$22.7M
- Jan 2022Series A$22.7M
- Mar 2019Series A$3.4M
#4
Series A · Paris, Ile de France · founded 2024$35Mraised▾
Developer of AI foundation model to transform biological research. The company's model would integrate different scales of biological data, from molecules to cells to tissues, to reveal new insights. It fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- Jan 2025Series A$41M
- Feb 2024Seed$35M
#5
Series B · Paris, Ile de France · founded 2018 · 35 employees$2.2Mraised▾
Primaa is a developer of AI-based software for automated and accurate histological diagnoses. The software is designed to assist pathology diagnosis. The product is based on image processing and artificial intelligence.
- Oct 2025Series B$8.2M
- Nov 2024Series A$5.4M
- Oct 2019Seed$2.2M
- Jul 2019Grant (prize money)$44.8K
#6
Seed · Paris, Ile de France · founded 2022 · 6 employees$7.7Mraised▾
Developer of bioproduction platform for drug discovery and development. It offers a platform that offers a technology that enables the yield of therapeutic proteins produced in mammalian cell factories by harnessing efficient processes from diverse organisms to revolutionize drug production.
- May 2025Seed$6.2M
- Jul 2023Grant (prize money)$84.3K
- Jul 2023Grant (prize money)$81.9K
- 2022Seed$1.3M
#7
Series A · Paris, Ile de France · founded 2019 · 10 employees$16.4Mraised▾
Provider of AI-based drug discovery and omics analysis tool for researchers. The company has developed tools that are AI-enabled for the process of drug discovery. The tool assists in provided insights for target protein for the drug for an individual patient. The tools use machine learning technology to identify molecular triggers for the drug and target identification. It has features to process biological data, tools for genomic screening, and more.
- Dec 2024Series A$10.5M
- Oct 2022Series A$5.9M
#8
Seed · Sucy-en-Brie, Ile-de-France · founded 2024$6.3Mraised▾
AI-powered platform to accelerate scientific innovation and improve knowledge management in the life sciences industry. It provide AI solutions to simplify the complexities of drug development, ensuring accurate, timely results, regulatory compliance and document management.
- Nov 2024Seed$6.3M
#9
Series D · Meylan, Auvergne Rhone Alpes · founded 2003 · 12 employees$36.2Mraised▾
Provider of electronic clinical outcome assessment solutions for clinical trials. The company delivers a platform adaptable to protocol, population, and questionnaire requirements. It offers tools for data management, real-time data access, and in-depth analytics. The platform provides multiple data collection modes and patient engagement features. It also facilitates integration with other clinical systems to streamline data flow.
- Mar 2023Series D$2.4M
- Mar 2023Conventional Debt$3M
- Dec 2020Series D$8.4M
- Oct 2016Series C$4M
#10
Series A · Paris, Ile de France · founded 2016 · 49 employees$35.5Mraised▾
AI-based patient recruitment platform. The company offers an AI-based patient recruitment system, intending to accelerate recruitment by enabling data-driven site selection. It provides end-to-end personalized site selection by identifying potential sites, gathering information on each site, analyzing recruitment capabilities, modeling and optimizing recruitment, and more.
- Mar 2023Series A$20M
- Feb 2020Series A$14M
- Nov 2017Seed$1.5M
#11
Series E · Paris, Ile de France · founded 2008 · 70 employees$129.7Mraised▾
Developer of immunomodulatory drugs targeting cancer and immune diseases. The company develops drugs based on the ability to de-code the gut microbiome’s interaction with the immune system. The company has developed two technology platforms which include OncoMimics therapeutic cancer vaccines, and EndoMimics an oral bioactive to treat inflammatory and autoimmune diseases.
- Jun 2020Series E$52.3M
- Jan 2018Conventional Debt$48.1M
- Jan 2018Series D$38.5M
- Apr 2016Series C$16.4M
#12
Series A · Paris, Ile de France · founded 2012 · 68 employees$47Mraised▾
Provider of solutions for single-molecule genetic and epigenetic sequencing. The platform technology SIMDEQ (SIngle-molecule Magnetic Detection and Quantification), initially developed at École Normale Supérieure (ENS), exploits the biophysical properties of DNA and RNA to enable genetic and epigenetic sequencing. The DNA and RNA are converted into a 'hairpin' library that is immobilized on a magnetic bead. Under the influence of a magnetic field, these hairpins are 'zipped' and 'unzipped'.
- Dec 2021Series A$34.5M
- Oct 2021Grant (prize money)$115.6K
- Nov 2018Grant (prize money)$2.3M
- Dec 2016Grant (prize money)$52.7K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in France
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,220 France-affiliated papers.
- Centre National de la Recherche Scientifique280
- Inserm169
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement144
- Ministry of Agriculture118
- AgroParisTech36
- Gene3→26
- Genome2→14
- Antibody1→10
- Cell culture1→10
- Mutant1→10
- Gene2→30
- Agriculture1→20
- Selection (genetic algorithm)2→18
- Resistance (ecology)2→16
- Population1→12
- Agriculture2→13
- Antibiotic resistance3→12
- Population1→9
- Public health1→8
- Context (archaeology)2→9
Where biotechnology is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in France
France biotechnology patent filing is cooling — 34,222 filings from 8,000 assignees (2016–2025), led by Centre NAT RECH Scient, INST NAT Sante RECH MED, Sanofi; annual filings 3501→2745.
- Centre NAT RECH Scient10040
- INST NAT Sante RECH MED8292
- Sanofi3990
- Pasteur Institut3416
- Agronomique INST NAT RECH1331
- Cellectis1320
- PF Medicament1203
- Commissariat Energie Atomique1151
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.